Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.
| Distributed by / for | Precision Dose Inc. |
| NDC | 68094-204-62 |
| Full product label | Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per case, NDC: 68094-204-62; 10 mL x 100 Unit Dose Cups per case, NDC: 68094-204-61; Unit Dose Cup NDC: 68094-204-59], Rx only, Precision Dose, Inc., South Beloit, IL 61080 |
| Recalling firm | Precision Dose Inc. |
| Distribution | Nationwide USA |
| Quantity | 224,940 unit dose cups |
| Recall initiated | 2019-11-13 |
| Report date | 2020-03-18 |
| Recall completed | 2022-09-17 |
| Recall number | D-1004-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | South Beloit IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗